GlassScriptPhysician profile
Stacy R Trinkle
NPI 1114982683
$1,634.58
in general payments reported to CMS, 2019-2025
20 companies · $241 in 2025
The $241 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,207 · 2020: $103 · 2023: $18.79 · 2024: $64.71 · 2025: $241.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $324.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $324.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $415.83 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $152.82 | 2019-2025 | Mounjaro, Zepbound |
| Pfizer INC. | $145.28 | 2019-2025 | |
| Astellas Pharma US INC | $130.90 | 2019-2025 | Veozah |
| Janssen Pharmaceuticals, INC | $130.06 | 2019 | |
| Amgen INC. | $109.28 | 2019-2025 | Repatha, Otezla |
| Sanofi-Aventis U.S. LLC | $98.26 | 2019 | |
| Glaxosmithkline, LLC. | $94.48 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $68.44 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $51.77 | 2019-2020 | |
| Allergan, INC. | $51.55 | 2019 | |
| Abbvie INC. | $41.28 | 2019-2025 | |
| Amarin Pharma, INC. | $31.53 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.69 | 2019 | |
| Dynavax Technologies Corporation | $18.33 | 2025 | Heplisav-B |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $15.85 | 2025 | Freestyle Libre 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $13.84 | 2019 | |
| Merck Sharp & Dohme LLC | $11.74 | 2019 | |
| Assertio Therapeutics, INC. | $11.47 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Trinkle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.